X0306 4 2018-05-17 0 0001337013 InfuSystem Holdings, Inc INFU 0001601397 Meridian OHC Partners, LP 425 WEED STREET NEW CANAAN CT 06840 0 0 1 0 0001601536 Meridian TSV II, LP 425 WEED STREET NEW CANAAN CT 06840 0 0 1 0 0001603326 TSV Investment Partners, LLC 425 WEED STREET NEW CANAAN CT 06840 0 0 1 0 0001460781 BlueLine Capital Partners II, L.P. 3480 BUSKIRK AVENUE SUITE 214 PLEASANT HILL CA 94523 0 0 1 0 0001311443 BlueLine Partners, L.L.C. 3480 BUSKIRK AVENUE SUITE 214 PLEASANT HILL CA 94523 0 0 1 0 Common Stock 2018-05-17 4 P 0 5000 2.90 A 3177867 D Common Stock 2018-05-18 4 P 0 944 2.85 A 3178811 D Common Stock 2018-05-18 4 P 0 841 2.85 A 3179652 D Common Stock 2018-05-22 4 P 0 5000 3.00 A 3184652 D These securities are owned by BlueLine Capital Partners II, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. These securities are owned by Meridian TSV II, LP. The amount of securities beneficially owned by the Reporting Persons was incorrectly stated on the Form 4 filed on May 24, 2017 and was reflected in all subsequent reports but is being corrected with this Form 4 filing. /s/ Scott A. Shuda 2018-05-22